TY  - GEN
AU  - Lewin,Jeremy
AU  - Soria,Jean-Charles
AU  - Stathis,Anastasios
AU  - Delord,Jean-Pierre
AU  - Peters,Solange
AU  - Awada,Ahmad
AU  - Aftimos,Philippe G
AU  - Bekradda,Mohamed
AU  - Rezai,Keyvan
AU  - Zeng,Zhen
AU  - Hussain,Azher
AU  - Perez,Susan
AU  - Siu,Lillian L
AU  - Massard,Christophe
TI  - Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
SN  - 1527-7755
PY  - 2019///0913
KW  - Acetanilides
KW  - administration & dosage
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2018.78.2292
ER  -